Chabiotech Co Ltd
KOSDAQ:085660
Intrinsic Value
Cha Biotech Co., Ltd. engages in the research of cell therapy and storage of cord blood. [ Read More ]
The intrinsic value of one Chabiotech Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 17 000 KRW, Chabiotech Co Ltd is hidden .
Valuation Backtest
Chabiotech Co Ltd
Run backtest to discover the historical profit from buying and selling Chabiotech Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
This note will be permanently deleted.
Balance Sheet Decomposition
Chabiotech Co Ltd
Current Assets | 538.2B |
Cash & Short-Term Investments | 202.3B |
Receivables | 255.3B |
Other Current Assets | 80.6B |
Non-Current Assets | 1.2T |
Long-Term Investments | 101.7B |
PP&E | 853.5B |
Intangibles | 87.1B |
Other Non-Current Assets | 145.1B |
Current Liabilities | 646.2B |
Accounts Payable | 80.3B |
Accrued Liabilities | 35.5B |
Short-Term Debt | 22.1B |
Other Current Liabilities | 508.2B |
Non-Current Liabilities | 798.1B |
Long-Term Debt | 141.7B |
Other Non-Current Liabilities | 656.3B |
Earnings Waterfall
Chabiotech Co Ltd
Revenue
|
954B
KRW
|
Cost of Revenue
|
-677.6B
KRW
|
Gross Profit
|
276.4B
KRW
|
Operating Expenses
|
-285.9B
KRW
|
Operating Income
|
-9.6B
KRW
|
Other Expenses
|
1.1B
KRW
|
Net Income
|
-8.4B
KRW
|
Free Cash Flow Analysis
Chabiotech Co Ltd
KRW | |
Free Cash Flow | KRW |
Profitability Score
Profitability Due Diligence
Chabiotech Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
Chabiotech Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Chabiotech Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
Chabiotech Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Chabiotech Co Ltd
According to Wall Street analysts, the average 1-year price target for Chabiotech Co Ltd is 21 400 KRW .
Shareholder Return
Price
Chabiotech Co Ltd
Average Annual Return | -3.23% |
Standard Deviation of Annual Returns | 30.15% |
Max Drawdown | -60% |
Market Capitalization | 957.3B KRW |
Shares Outstanding | 56 314 400 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Cha Biotech Co., Ltd. engages in the research of cell therapy and storage of cord blood. The company is headquartered in Seoul, Seoul. The company went IPO on 2005-12-27. is a Korea-based company mainly engaged in the bio business. Along with its subsidiaries, the Company operates its business through two segments: bio segment and optical segment. Its bio segment engages in the provision of medical services; development of stem cells and cell therapy products; production of cosmetics and cosmetic raw materials; distribution of medical devices and others, as well as cord blood storage, health care services and others. Its optical segment engages in the manufacture of optical lenses, optical modules and other parts, which are used in mobile phone cameras.
Contact
IPO
Employees
Officers
The intrinsic value of one Chabiotech Co Ltd stock under the Base Case scenario is hidden KRW.
Compared to the current market price of 17 000 KRW, Chabiotech Co Ltd is hidden .